AbbVie (NYSE:ABBV) announced on Thursday that the company has reached settlements with all generic drugmakers to resolve ...

AbbVie has settled with each of the drugmakers that have filed for FDA approval of Rinvoq generics, preventing copycat ...

The news that the brand is protected from generics for more than a decade "gives AbbVie a kind of tremendous runway," to sell ...

Penn researchers say they will pursue larger-scale studies to continue testing whether hydroxychloroquine and everolimus can ...

One of the great triumphs of health policy is America’s generic drug market. Nine out of ten U.S. prescriptions are filled with generics. That overwhelming share saves patients and taxpayers hundreds ...

The biopharmaceutical company doesn’t expect U.S. generic entry for the drug before 2037 now that it has settled litigation.

Biocon CEO Siddharth Mittal reveals plans to launch generic versions of diabetes drug Ozempic in key markets by the end of ...

Rapamycin is an immune suppressant often used in organ transplant patients, but it has also been shown to extend life in ...

While 2025 began on a positive note for the pharmaceutical industry, things have taken a sharp turn amid escalating fears of a global trade war. While Trump had initially exempted pharmaceuticals from ...

The real question is how to re-shore pharmaceutical production while minimizing the costs to patients, economist Tomas J.

Virginia has outpaced the national average in Medicaid spending, an analysis of data by groups of pharmacists found. The ...